XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Pay vs Performance Disclosure - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Pay vs Performance Disclosure [Table]      
Pay vs Performance [Table Text Block]
The following table sets forth information concerning the compensation of our PEO and
non-PEO
NEOs for the fiscal years ended December 31, 2022, 2021 and 2020, and our financial performance for each such fiscal year:
 
                                
Value of Initial $100 Fixed
Investment Based on (3)
                
Year
   
Summary
Compensation
Table Total
for PEO ($)
     
Compensation
Actually Paid
to PEO ($)
(1)(2)
     
Average
Summary
Compensation
Table Total for
non-PEO NEOs

($)
     
Average
Compensation
Actually Paid
to
non-PEO

NEOs ($)
     
Total
Shareholder
Return ($)
     
Peer Group
Total
Shareholder
Return ($)
     
Net
Income (in
thousands)
($)
     
Net Product
Revenue (in
thousands)
($)
  
2022
      6,923,782        17,549,684        2,674,788        7,393,846        496        69        83,079        213,938  
2021
      2,089,432        5,369,277        1,361,793        2,328,165        181        94        39,482        137,997  
2020
      1,762,272        1,544,344        1,245,629        1,099,682        89        113        74,983        118,790  
 
(1)
Amounts represent “compensation actually paid” (“
CAP
”) to our PEO and the average compensation actually paid to our
non-PEO
NEOs for the relevant fiscal year, as determined under SEC rules (and described below).
(2)
Fair value or change in fair value, as applicable, of stock options in the “Compensation
Actually
Paid” columns was estimated using a Black-Scholes option pricing model for the purposes of this disclosure in accordance with SEC rules and do not reflect compensation actually earned, realized or received during each applicable year. The calculation of CAP for purposes of this table includes
point-in-time
fair values of equity awards and those values will fluctuate based on our stock price and various accounting valuation assumptions. See the Summary Compensation Table for certain other compensation of our PEO and our
non-PEO
NEOs for each applicable fiscal year.
(3)
For the relevant fiscal year, represents our cumulative “total shareholder return” (“
TSR
”) or the cumulative TSR of the Nasdaq Biotechnology Index, in each case assuming an initial investment of $100 as described under the Narrative Disclosure to Pay Versus Performance heading below. We have never declared or paid a dividend on our common stock and do not anticipate doing so in the foreseeable future.
 
In the table immediately above, the columns “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to
non-PEO
NEOs” reflect the Total Compensation reported in the 2022 Summary Compensation Table (“
SCT
”), as adjusted based on the following:
 
    
SCT Total ($)
     
Minus SCT
Equity
Awards ($)
     
Plus Value of
New Unvested
Awards as of
12/31 ($)
     
Plus Annual
Change in
Value of Prior
Year Awards
that Remain
Unvested ($)
    
Plus Value of
Awards
Vested and
Granted
During Year
($)
     
Plus Change
in Value of
Prior Year
Awards that
Vest During
Year ($)
     
Total CAP ($)
  
PEO
                    
2022
      6,923,782        5,727,859        7,659,348        3,460,212       —          5,234,201        17,549,684  
2021
      2,089,432        1,041,324        978,593        1,424,326       —          1,918,250        5,369,277  
2020
      1,762,272        834,093        808,368        (264,158 )      —          71,955        1,544,344  
Average
Non-PEO
NEOs
 
              
2022
      2,674,788        1,939,664        2,316,864        2,394,265       —          1,947,593        7,393,846  
2021
      1,361,793        767,761        804,173        456,388       —          473,572        2,328,165  
2020
      1,245,629        652,457        574,265        (70,986 )      —          3,231        1,099,682  
The following tables illustrate the valuation assumptions as of the vesting date for awards that vested in each of 2022, 2021 and 2020.
 
    
For Stock Options Vesting in
    
2022
   
2021
   
2020
Risk-free interest rate
   
1.30% - 4.00%
   
0.35% - 1.17%
   
0.24% - 1.53%
Expected term
    4.5 years    4.5 years    4.5 years
Expected volatility
    68.4% - 69.5%    68.6% - 72.8%    80.5% - 83.7%
Expected dividend yield
    —      —      —  
Expected forfeiture rate
    —      —      —  
 
    
Weighted Average Fair Value of Full Value
Awards Vesting in
  
    
2022
     
2021
     
2020
  
For Restricted Stock Units
    $ 4.65      $ 4.65      $ 4.64  
    
Company Selected Measure Name Net Product Revenue    
Named Executive Officers, Footnote [Text Block]
The Company’s principal executive officer (“
PEO
”) and our
non-PEO
named executive officers (“
NEO
s”) were as follows for the fiscal years ended December 31, 2022, 2021 and 2020:
 
Year
   
PEO
   
Non-PEO
NEOs
2022   
Patrick J. McEnany
   
Alicia Grande, Steven Miller, Gary Ingenito, Jeffrey Del Carmen
2021   
Patrick J. McEnany
   
Alicia Grande, Steven Miller, Gary Ingenito, Preethi Sundaram
2020   
Patrick J. McEnany
   
Alicia Grande, Steven Miller, Gary Ingenito, Jeffrey Del Carmen
    
Peer Group Issuers, Footnote [Text Block] For the relevant fiscal year, represents our cumulative “total shareholder return” (“
TSR
”) or the cumulative TSR of the Nasdaq Biotechnology Index, in each case assuming an initial investment of $100 as described under the Narrative Disclosure to Pay Versus Performance heading below. We have never declared or paid a dividend on our common stock and do not anticipate doing so in the foreseeable future. 		   
PEO Total Compensation Amount $ 6,923,782 $ 2,089,432 $ 1,762,272
PEO Actually Paid Compensation Amount 17,549,684 5,369,277 1,544,344
Non-PEO NEO Average Total Compensation Amount 2,674,788 1,361,793 1,245,629
Non-PEO NEO Average Compensation Actually Paid Amount $ 7,393,846 2,328,165 1,099,682
Compensation Actually Paid vs. Total Shareholder Return [Text Block]
TSR amounts reported in the graph assume an initial fixed investment of $100 on January 1, 2020 and, with respect to our cumulative TSR, based on the opening trading price on such date.
 
LOGO 		   
Compensation Actually Paid vs. Net Income [Text Block] LOGO    
Compensation Actually Paid vs. Company Selected Measure [Text Block] LOGO    
Total Shareholder Return Vs Peer Group [Text Block]
TSR amounts reported in the graph assume an initial fixed investment of $100 on January 1, 2020 and, with respect to our cumulative TSR, based on the opening trading price on such date.
 
LOGO 		   
Total Shareholder Return Amount $ 496 181 89
Peer Group Total Shareholder Return Amount 69 94 113
Net Income (Loss) $ 83,079,000 $ 39,482,000 $ 74,983,000
Company Selected Measure Amount 213,938,000 137,997,000 118,790,000
PEO Name Patrick J. McEnany    
Measure [Axis]: 1      
Pay vs Performance Disclosure [Table]      
Measure Name Net Product Revenue    
Measure [Axis]: 2      
Pay vs Performance Disclosure [Table]      
Measure Name Net Income    
Measure [Axis]: 3      
Pay vs Performance Disclosure [Table]      
Measure Name Completion of a transformational acquisition    
Measure [Axis]: 4      
Pay vs Performance Disclosure [Table]      
Measure Name Quality and Compliance    
PEO [Member] | SCT Equity Awards [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount $ (5,727,859) $ (1,041,324) $ (834,093)
PEO [Member] | Value of New Unvested Awards [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 7,659,348 978,593 808,368
PEO [Member] | Annual Change in Value of Prior Year Awards that Remain Unvested [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 3,460,212 1,424,326 (264,158)
PEO [Member] | Change in Value of Prior Year Awards that Vest During Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 5,234,201 1,918,250 71,955
Non-PEO NEO [Member] | SCT Equity Awards [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (1,939,664) (767,761) (652,457)
Non-PEO NEO [Member] | Value of New Unvested Awards [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 2,316,864 804,173 574,265
Non-PEO NEO [Member] | Annual Change in Value of Prior Year Awards that Remain Unvested [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 2,394,265 456,388 (70,986)
Non-PEO NEO [Member] | Change in Value of Prior Year Awards that Vest During Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount $ 1,947,593 $ 473,572 $ 3,231